Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent.

Abstract

Following intravenous administration of ketanserin (0.3-10 mg kg-1) to conscious or anaesthetized normotensive and spontaneously hypertensive rats there were dose-dependent blood pressure reductions but no compensatory tachycardia. Intracerebroventricular administration of ketanserin (25-500 microgram) had inconsistent and largely insignificant cardiovascular effects. In a dose range where it produces hypotension ketanserin antagonized the pressor responses to adrenaline and noradrenaline as well as to 5-hydroxytryptamine in monoamine depleted and spinalized rats. It is suggested that the hypotensive action of ketanserin in the rat does not involve a central mechanism but a peripheral alpha-adrenolytic action is implicated.

Statistics

0200400600'85'88'91'94'97'00'03'06'09'12'15
Citations per Year

783 Citations

Semantic Scholar estimates that this publication has 783 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Persson1982CardiovascularEI, title={Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent.}, author={Bengt H. Persson and Thomas Hedner and Matts Henning}, journal={The Journal of pharmacy and pharmacology}, year={1982}, volume={34 7}, pages={442-5} }